Form D · Private Equity Fund
OrbiMed Israel Partners II, L.P.
New York, NY · CIK 0001660278
Offering snapshot reported Dec 14, 2015 · SEC filing
- Reported sold
- Yet to sell Offering amount: $300M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 14, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-253036
Source: Form D, filed Dec 14, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
ORBIMED ISRAEL PARTNERS II, L.P.
Investment adviser: ORBIMED ADVISORS LLC
- Gross asset value
- $298M
- Beneficial owners
- 116
- ADV minimum commitment
- $5M
Reported in Form ADV on Aug 18, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- Yes
- External marketing
- No
BRIGHTMAN ALMAGOR ZOHAR & CO.
PCAOB 1197
JPMORGAN CHASE BANK, N.A.
LEI 7H6GLXDRUGQFU57RNE9
Filing source
Form ADV 2126532 · Aug 18, 2026 · Schedule D 7.B.(1), fund 805-5094083814
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Erez Chimovits | Executive |
| Nissim Darvish | Executive |
| Carl L. Gordon | Executive |
| Samuel D. Isaly | Promoter |
| Anat Naschitz | Executive |
| W. Carter Neild | Promoter |
| N/A N/A Orbi Med Advisors Israel Ii Limited | Executive, Promoter |
| N/A N/A Orbi Med Israel Gp Ii, L.P. | Executive, Promoter |
| Jonathan T. Silverstein | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10022